Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

dutchfella

Rank: Mail Room [?]

Points: 141 [?]

Votes: 15 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara

in response to

Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara

BearDownAZ

posted on Jan 07, 2020 11:59AM

A little specificity from Don on the dates of future conferences and publications would be appreciated. Vagueness on timing has always been an issue with ZEN and RVX.

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply